CMS Archives | Chilmark Research

by Brian Murphy | May 22, 2019

What Will ONC Do With TEFCA?

Chilmark Bight from May 2018: Major issues raised by stakeholders about the 1st draft of TEFCA ONC’s draft Trusted Exchange […]

Share

by Robert Tholemeier | April 30, 2019

How Far Have We Progressed on True Continuous Costing?

Three years ago, our report Making Healthcare Affordable: Implementing True Continuous Costing explored the need for, and benefits of, implementing […]

Share

by Matt Guldin | February 04, 2019

Webinar — Bundled Payments: Current Strategies and Tools

In this webinar, Chilmark Analyst Matt Guldin presents key findings from our report, Bundled Payments: Current Strategies and Tools. Afterward, […]

Share

by Matt Guldin | December 13, 2018

What Are Bundled Payments and Are They Here to Stay?

Key Takeaways Current vendor solutions are limited and generally require additional advisory services. Few available solutions offer workflow integration, especially […]

Share

by Matt Guldin | November 27, 2018

Is Radiation Oncology Ready for Alternative Payments?

HHS Secretary Alex M. Azar II’s recent speech to the Patient-Centered Primary Care Collaborative in Washington, DC, indicated that there is a significant change in thinking of CMS about value-based-care and voluntary vs. mandatory participation in alternative payment model (APM) programs.

Share

by Chilmark Team | November 13, 2018

How will Proposed Changes to CMS Telehealth Reimbursement Affect Adoption?

On Friday, October 26, the Centers for Medicare and Medicaid Services (CMS) announced several rule changes that affect how telehealth services will be covered under Medicare Advantage (MA) and the Medicare prescription drug program (Part D). These changes are in direct response to the Bipartisan Budget Act of 2018, which eliminated historical restrictions on telehealth reimbursement, and are intended to “improve quality of care and provide more plan choices for MA and Part D enrollees.”

Share

by John Moore | August 14, 2018